Zevra Therapeutics Inc. (ZVRA) — Tangible Net Worth Ratio
Zevra Therapeutics Inc. (ZVRA) has a Tangible Net Worth Ratio of 94.9% as of September 2025. This metric is calculated by deducting intangible assets ($6.74 Million) from net assets ($133.16 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Zevra Therapeutics Inc. (ZVRA) net asset momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Zevra Therapeutics Inc. Tangible Net Worth Ratio (2021–2024)
This chart shows how Zevra Therapeutics Inc.'s Tangible Net Worth Ratio has changed across 4 annual periods from 2021 to 2024. As of September 2025, the ratio stands at 94.9%, reflecting net assets of $133.16 Million with intangible assets of $6.74 Million USD. For live market cap and overall valuation, see market cap of Zevra Therapeutics Inc..
Annual Tangible Net Worth Ratio for Zevra Therapeutics Inc. (2021–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Zevra Therapeutics Inc. from 2021 to 2024, covering 4 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore Zevra Therapeutics Inc. capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | -73.9% | $39.67 Million | $68.99 Million | $178.13 Million | ▼ -62.0 pp |
| 2023 | -11.9% | $61.86 Million | $69.23 Million | $172.33 Million | ▼ -111.9 pp |
| 2022 | 100.0% | $75.12 Million | $0.00 | $115.34 Million | ▲ +0.0 pp |
| 2021 | 100.0% | $127.12 Million | $0.00 | $132.94 Million | — |